HOME >> MEDICINE >> NEWS
Spinifex secures $3.25m investment to develop pain therapy

A pain drug development company spun out of The University of Queensland has received a $3.25 million investment commitment to develop its innovative new pain therapy.

Spinifex Pharmaceuticals, an emerging biotechnology company specialising in the development of therapeutics for the treatment of neuropathic pain, has attracted investment from a syndicate including Symbiosis Group Limited, Melbourne-based GBS Venture Partners Limited and Uniseed.

Spinifex Pharmaceutical Managing Director, Dr Michael Thurn said he was delighted by the investment commitment which will help to accelerate their drug development program.

"We've several promising small molecules currently under evaluation and we plan to be in a position to start a formal toxicology program on one of those molecules in 2006," said Dr Thurn.

"The two main causes of neuropathic pain are through diabetes, affecting an estimated 45 per cent of diabetics, and through complications arising from infection with herpes zoster [shingles], known as post-herpetic neuralgia.

"We see a significant world-wide market for our pain therapy, and this investment will progress our efforts in delivering a novel solution."

Spinifex's core technology relates to the discovery (made by University of Queensland researchers led by Professor Maree Smith) of a novel pathway for the treatment of neuropathic pain. Professor Smith's group successfully validated this pathway using small molecules in well-defined animal models of neuropathic pain.

Managing Director of investment company Symbiosis, Dr Mark Harvey, said Spinifex was an attractive investment, led by a strong team with extensive experience in the international and local biotechnology industry

He said the neuropathic pain market targeted by Spinifex's technology was currently valued at US$3 billion.

"With a solid intellectual property position and several 'drug-like' molecules already in hand we expe
'"/>

Contact: Dr Michael Thurn
61-7-3842-3153
Research Australia
26-Jul-2005


Page: 1 2

Related medicine news :

1. University of Rochester spin-off secures $2 million in funding
2. Medical College of Wisconsin secures key contract from US HRSA
3. Molecular Profiling Institute secures $7.5 million in Series B funding
4. Menzies secures $1.8m in funding for the NT
5. ASU secures $3.9 million to study spinal cord injuries and neurological disorders
6. Damon Runyon renews its $2.25 million investment to support young clinical cancer investigators
7. New PBS investment as PBS slows
8. Industry welcomes massive Victorian investment in medical research
9. European Science Foundation warns nanomedicine benefits will be lost without major investment
10. Medicares investment in quality improvement may not be paying off
11. Baby DVDs, videos may hinder, not help, infants language development

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Spinifex secures investment develop pain therapy

(Date:8/22/2014)... 2014 The first ORTC Public ... Microsoft, and Google. ( http://ortc.org/wp-content/uploads/2014/08/ortc.html ) , ... to create a WebRTC 1.1 API with exceptional ... WebRTC, ORTC (Object Real-time Communication) enables plugin-free real-time ... specifically tailored to provide the direct control needed ...
(Date:8/22/2014)... California (PRWEB) August 22, 2014 The ... , BillionaireFish.com, recently registered its two millionth member, and ... threshold. , Billionairefish.com is a dating website for ... women to date. The dating website caters like-minded people ... dating site for the rich , this is ...
(Date:8/22/2014)... New York, NY (PRWEB) August 22, 2014 ... at NY Heart Health Clinics are promoting non-invasive ... four most preventable risks of cardiovascular morbidity and ... heart disease, stroke, Deep Vein Thrombosis and Pulmonary ... Health Clinics are promoting painless, noninvasive screening at ...
(Date:8/22/2014)... CA (PRWEB) August 22, 2014 AttorneyOne.com, ... regarding all the latest information from the FDA on ... , The US FDA announced on August 19, that ... Systems, model number DPB-125MICRO145 (Part number 7-10003), by Cardiovascular ... defective saline sheaths that could fracture during use and ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 The Berkowitz ... behalf of a client who suffered severe, permanent injuries ... old drunk driver (docket number FST-CV13-6018309-S). The case was ... mediation. , According to Jennifer Amdur of The Berkowitz ... the case, all of whom were allegedly ...
Breaking Medicine News(10 mins):Health News:Hookflash, Google and Microsoft lead on ORTC / WebRTC 1.1 Public Draft 2Health News:Hookflash, Google and Microsoft lead on ORTC / WebRTC 1.1 Public Draft 3Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 2Health News:Rich Men & Women Dating Site Billionairefish.com Exceeds Two Million Members 3Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 2Health News:NY Heart Health Clinics Created by Dr. David Greuner and Dr. David Luu of NYC Surgical Associates 3Health News:Diamondback 360 Peripheral Orbital Atherectomy System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:The Berkowitz Law Firm LLC Reaches a $2 Million Settlement for a Client Allegedly Injured in Drunk Driving Accident 2
(Date:8/21/2014)... Aug. 21, 2014   Auxilium Pharmaceuticals, Inc. ... biopharmaceutical company, today announced positive results from a ... histolyticum (or CCH) for the treatment of edematous ... the Phase 2a trial, all three doses of ... showed an improvement in the appearance of cellulite ...
(Date:8/20/2014)... , Aug. 20, 2014  The National ... the latest results achieved by the real-time, pseudoephedrine ... the National Precursor Log Exchange (NPLEx), automatically blocks ... track down meth offenders and make arrests. Data ... Indiana blocked the sale of ...
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Indiana's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
Cached News: